Alan H. Auerbach

Alan H. Auerbach

President and Chief Executive OfficeratPuma Biotechnology· In proxies 2021–2025

Pay in FY2025-23% from the year before · Puma Biotechnology stock +95.1% the same year

Alan H. Auerbach was paid $3.1M in FY2025 (Dec), down 23%. Puma Biotechnology stock rose 95.1% that year.

Pay$100 in the stock at the end of FY20 → $58
Pay is from the Summary Compensation Table of each Puma Biotechnology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Puma BiotechnologyPublic company · 5 yr
    • President and Chief Executive Officer2021 – Present · 5 yrStock in role -7%

Roles come from the proxy statements of each company.

Boards1

  • Puma BiotechnologyChair · 15 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?